Skip to main content
Onesource Specialty Pharma Limited logo

Onesource Specialty Pharma Limited — Investor Relations & Filings

Ticker · ONESOURCE ISIN · INE013P01021 LEI · 335800TP5C932B9IQT98 BSE.NS Manufacturing
Open in API
Filings indexed 156 across all filing types
Latest filing 2026-05-13 Investor Presentation
Country IN India
Listing BSE.NS ONESOURCE

About Onesource Specialty Pharma Limited

https://www.onesourcecdmo.com/

Onesource Specialty Pharma Limited is a specialized Contract Development and Manufacturing Organization (CDMO) providing integrated solutions for complex pharmaceutical products. The company focuses on the development and large-scale manufacturing of specialty injectables, softgel capsules, and complex formulations. Its service portfolio encompasses the entire product lifecycle, including formulation development, clinical trial supply, and commercial-stage production. Onesource operates advanced manufacturing facilities designed to meet global regulatory standards, catering to diverse therapeutic areas. By leveraging technical expertise in sterile products and differentiated dosage forms, the organization supports global pharmaceutical partners in bringing high-entry-barrier medicines to market. The platform is built on a foundation of quality compliance and operational excellence to ensure the delivery of critical healthcare solutions.

Recent filings

Filing Released Lang Actions
Investor Presentation
Investor Presentation Classification · 91% confidence The document is a press release announcing Q4FY26 and FY26 results, but it then transitions into a full slide deck (“Investor Presentation | Q4 & FY26”) with detailed charts, financial snapshots, strategy, business updates, and guidance. This is characteristic of an Investor Presentation, not just an earnings announcement (ER) or formal interim report (IR). Therefore, the most appropriate classification is IP (Investor Presentation).
2026-05-13 English
General Updates
M&A Activity Classification · 85% confidence The document is a stock exchange filing addressed to BSE and NSE, titled “Update on Composite Scheme of Arrangement and Amalgamation (Merger by Absorption)”. It informs shareholders and regulators about the decision to not pursue the proposed merger in its current form. This is clearly an announcement related to M&A activity (scheme of arrangement/merger). It does not present financial statements or management discussion (thus not an IR or 10-K), nor is it simply a dividend, share issue, or director’s dealing. Therefore, it falls under the M&A Activity category (Code: TAR).
2026-05-13 English
Appointment of BSR & Co.LLP Chartered Accountants as the Statutory Auditors of the Company.
Interim / Quarterly Report Classification · 87% confidence The document is a formal SEBI Listing Regulation 30 announcement titled “Outcome of Board meeting,” disclosing and enclosing the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2026 along with the full Auditors’ Report. It contains actual financial statements and the auditor’s opinion – not merely a short notice that a report is available. This goes beyond a simple earnings highlight and constitutes the substantive quarterly (and year‐end) financial results filing. Therefore, it aligns with an Interim/Quarterly Report rather than a mere release of highlights or a report publication notice. FY 2026
2026-05-13 English
Allotment of 3,150 Equity Shares of Re.1/- each under ONESOURCE ESOP SCHEME 2021.
Share Issue/Capital Change Classification · 90% confidence The document is a stock exchange filing under SEBI regulations announcing the allotment of new equity shares under an ESOP plan and detailing the resulting change in share capital. This is a new share issue/capital change notification, matching the definition for code SHA (Share Issue/Capital Change).
2026-05-13 English
Change in Auditors
Regulatory Filings
2026-05-13 English
General Updates
Share Issue/Capital Change Classification · 87% confidence The document is an official stock exchange filing under SEBI Listing Regulations announcing the allotment of new equity shares under the company’s ESOP scheme, including details of the issue, share capital change, and ISIN. This is a corporate announcement regarding new share issuance (capital change), which fits the Share Issue/Capital Change category (Code: SHA).
2026-05-13 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.